Studies on antidiabetic agents. VI. Asymmetric transformation of (+/-)-5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4- thiazolidinedione(ciglitazone) with optically active 1-phenylethylamines.
D000818:Animals; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D007004:Hypoglycemic Agents / Q000138:chemical synthesis*; D051379:Mice; D008820:Mice, Obese; D010627:Phenethylamines; D013237:Stereoisomerism; D013844:Thiazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D010627:Phenethylamines; D013844:Thiazoles; D045162:Thiazolidinediones; C039671:ciglitazone